Navigation Links
Skin Cancer History Puts Post-menopausal White Women At Risk For Melanoma

A new study appearing in the online journal Cancer says that elderly white women who have had non-melanoma skin cancer are more likely to develop full blown melanoma regardless of their exposure to the harmful rays of the sun. //

The study found that women in the age group of 50 to 79, who had a previous history of basal cell carcinoma or squamous cell carcinoma of the skin, had a two-fold increase in the risk of developing cutaneous melanoma over 6.5 years. The study followed post-menopausal and non-Hispanic women. "This study adds a history of the relatively favorable non-melanoma skin cancer -- in and of itself -- to the list of known risk factors for melanoma in both sun lovers and shade dwellers alike," said lead author Carol A. Rosenberg, M.D., assistant professor medicine at Northwestern University Feinberg School of Medicine. "Our study further defines melanoma risk in post-menopausal women and, it is hoped, will sensitize the medical community to this risk, serving as a catalyst for development of new routines of follow-up and patient assessment to facilitate earlier detection of melanoma." She added that skin surveillance among such women could prove to be life-saving in the long run.

this is indeed a vital piece of news, since 1.3 million women are diagnosed with non-melanoma skin cancers each year, according to the American Cancer Society.

Melanoma is often very hard to treat if diagnosed in later stages since it has spread away from the initial site. "Diagnosing melanoma early is critical to saving lives," Rosenborg concluded.

Contact: Elizabeth Crown
e-crown@northwestern.edu
312-503-8928
Northwestern University
'"/>




Page: 1

Related medicine news :

1. Fibroids unlikely to Turn Cancerous
2. Virus Level could Predict Cervical Cancer Risk
3. Cancer Doctors Okays Controversial Prostate Therapy
4. Potential New Cancer Gene Identified
5. Consensus on "Combination Therapy" for Breast Cancer
6. Cancers of Colon & Rectum linked to Cigarette Smoking
7. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
8. The Cancer Rumour mill working over time
9. Cancer drugs in development nearly doubled since 1995
10. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
11. Cancer patients turning to Internet for information
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Skin Cancer History Puts Post menopausal White Women Risk For Melanoma

(Date:7/29/2015)... ... July 29, 2015 , ... ... with its Topricin® Pain Relief and Healing Cream designated as the nonprofit’s natural ... that is actively addressing Line of Duty Deaths (LODD) and the high rate ...
(Date:7/29/2015)... Miami, FL (PRWEB) , ... July 29, 2015 , ... ... on fruit flies revealed a gene which is directly responsible for stimulating and perpetuating ... was published in the journal entitled Proceedings of the National academy of Sciences, and ...
(Date:7/29/2015)... ... 29, 2015 , ... On July 26th the Miami ... for nicotine laced liquid products. Their report says cigarette use has decreased recently ... particularly troublesome to addiction professionals as many of the candy flavors available are ...
(Date:7/29/2015)... MI (PRWEB) , ... July 29, 2015 , ... ... for Southwest Michigan, changed its name in July to Kalamazoo Strength & Conditioning. ... http://www.kalamazoosc.com , and “reflects the evolution of our training center over the ...
(Date:7/29/2015)... , ... July 29, 2015 , ... San Fernando ... on Ultherapy. For a limited time only, patients can get the complete treatment process ... for patients who prefer a non-invasive treatment and have loose or sagging skin. ...
Breaking Medicine News(10 mins):Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 2Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 3Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 4Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 5Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 6Health News:Study Reveals Potential for Gene Manipulation to Stop Alcohol Addiction 2Health News:Study Reveals Potential for Gene Manipulation to Stop Alcohol Addiction 3Health News:Harbor Village Urges South Florida Residents to Abstain from the Use of E Cigarettes 2Health News:Harbor Village Urges South Florida Residents to Abstain from the Use of E Cigarettes 3Health News:Kalamazoo’s CrossFit 269 Changes Name, Opens New Website 2Health News:Kalamazoo’s CrossFit 269 Changes Name, Opens New Website 3Health News:Kalamazoo’s CrossFit 269 Changes Name, Opens New Website 4Health News:San Fernando Valley Dermatology Office, Castle Dermatology Institute, is Now Offering a Promotional Price on Ultherapy 2
... San Diego, Calif., USA Today, during the 89th ... Dental Research, held in conjunction with the 40th Annual ... the 35th Annual Meeting of the Canadian Association for ... oral presentation on a research study titled "Sealing Manifest ...
... Reporter , THURSDAY, March 17 (HealthDay News) -- Cutting-edge ... tremors, rigidity and other motor skill problems that are ... The phase 2 study enrolled 45 patients with ... to receive the gene therapy and half assigned to ...
... March 17, 2011 (BRONX, NY) The National Institutes ... Albert Einstein College of Medicine and Ferkauf Graduate ... identify cognitive factors that influence mobility in older people ... people remain active. , "Mobility limitations and disability in aging ...
... 2011) Many Baby Boomers will experience a bone fracture as ... prepared to provide the necessary care required, according to a ... Geriatric Orthopaedic Surgery and Rehabilitation (GOS), published by SAGE. ... II Baby Boom generation will reach 65 years old this ...
... at the University of Cincinnati (UC) and Cincinnati ... FDA-approved drug sirolimus, used primarily to prevent rejection ... women with lymphangioleiomyomatosis (LAM). The Multicenter International ... first randomized, controlled study designed to develop a ...
... HealthDay Reporter , WEDNESDAY, March 16 (HealthDay ... reached an all-time low in 2009, the 10th straight ... health officials report. , "There is basically good news," ... U.S. Centers for Disease Control and Prevention,s National Center ...
Cached Medicine News:Health News:Sealing manifest occlusal caries in permanent teeth -- 2.5-year results 2Health News:Gene Therapy May Help Reverse Parkinson's Symptoms 2Health News:Gene Therapy May Help Reverse Parkinson's Symptoms 3Health News:$3.4 million grant awarded to help older people stay mobile 2Health News:US healthcare system can't keep up with number of baby boomers' bone fractures 2Health News:New therapy found for rare lung disorder 2Health News:New therapy found for rare lung disorder 3Health News:U.S. Death Rate at All-Time Low: CDC 2Health News:U.S. Death Rate at All-Time Low: CDC 3
(Date:7/29/2015)... 2015   KaloBios Pharmaceuticals, Inc . (Nasdaq: ... innovative therapies to benefit patients with diseases of unmet ... that the U.S. Food and Drug Administration (FDA) has ... KB003, an anti-GM-CSF monoclonal antibody (mAb), in patients with ... now active. The acceptance of this IND ...
(Date:7/29/2015)... 27, 2015 Research and Markets ( http://www.researchandmarkets.com/research/sxwk89/3d_metrology ... Metrology Market by Product (CMM, ODS, and VMM), Application ... Geography (North America, Europe, APAC, RoW) - Global Forecast ... The 3D metrology market was valued at ... at a rate of 7.11% during the forecast period. ...
(Date:7/29/2015)... The Judicial Panel on Multidistrict Litigation (JPML) ... centralize Inferior vena cava (IVC) Filter lawsuits filed against ... have already been centralized by the JPML. ... risk for a pulmonary embolism. The filters are designed ... Claims against Bard and Cook involve incidents of retrievable ...
Breaking Medicine Technology:KaloBios Announces FDA Clearance of Investigational New Drug Application for KB003 in Patients with Chronic Myelomonocytic Leukemia 2KaloBios Announces FDA Clearance of Investigational New Drug Application for KB003 in Patients with Chronic Myelomonocytic Leukemia 3KaloBios Announces FDA Clearance of Investigational New Drug Application for KB003 in Patients with Chronic Myelomonocytic Leukemia 4KaloBios Announces FDA Clearance of Investigational New Drug Application for KB003 in Patients with Chronic Myelomonocytic Leukemia 5Global 3D Metrology Market 2015-2020: Products (CMM, ODS, and VMM) & Applications (Automotive, Aerospace, Energy & Power, Medical and Electronics) 2IVC filter litigation continues; law firm provides free information to IVC filter patients 2
... , , , ... AMGN ) today announced positive top-line results from a pivotal ... acid) administered as an intravenous (IV) infusion in the treatment of ... including breast and prostate cancer) or multiple myeloma. , ...
... , , , , ... Institute (KLRI) has published two new publications on hormone therapies and ... adults. , , Cardiovascular disease caused by atherosclerosis, ... greatest single killer of American women--40% of total deaths--and the rate ...
Cached Medicine Technology:Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R) 2Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R) 3Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R) 4Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R) 5Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R) 6Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R) 7Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R) 8TWO NEW KLRI PEER-REVIEWED PUBLICATIONS: Hormone Therapy May Reduce Atherosclerosis in Women Close to Menopause; Growth Hormone May Increase Risk of Diabetes, Improve Lipid Profile in Men 2TWO NEW KLRI PEER-REVIEWED PUBLICATIONS: Hormone Therapy May Reduce Atherosclerosis in Women Close to Menopause; Growth Hormone May Increase Risk of Diabetes, Improve Lipid Profile in Men 3
... Examination Tables deliver the highest quality care to ... types of patients can face a frustrating dilemma ... the exam table. Being able to easily get ... comfort during the exam, help the physician conduct ...
... This site introduces the DiamondTome™ ... with its unique DiamondTome™ Wands, an ... better way to smoother, more youthful ... we present the benefits of DiamondTome's™ ...
... Expand your practice with the advantages of ... effective treatment of leg veins and other deeper ... and fast. As a stand alone device or ... the Quantum DL treats a range of conditions ...
Inquire...
Medicine Products: